263868-71-9 Usage
General Description
5-(Tributylstannyl)-2-(trimethylsilyl)thiazole is a chemical compound that contains a thiazole ring with substituents at the 2 and 5 positions. The 2 position is occupied by a trimethylsilyl group, while the 5 position is occupied by a tributylstannyl group. Thiazole compounds are known for their diverse biological activities, including antibacterial, antifungal, and antitumor properties. The incorporation of organostannyl and trimethylsilyl groups in this compound may have implications for its reactivity and potential use in organic synthesis. 5-(Tributylstannyl)-2-(trimethylsilyl)thiazole could be of interest in the development of new pharmaceuticals or as a reagent in chemical reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 263868-71-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,8,6 and 8 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 263868-71:
(8*2)+(7*6)+(6*3)+(5*8)+(4*6)+(3*8)+(2*7)+(1*1)=179
179 % 10 = 9
So 263868-71-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H10NSSi.3C4H9.Sn/c1-9(2,3)6-7-4-5-8-6;3*1-3-4-2;/h4H,1-3H3;3*1,3-4H2,2H3;/rC18H37NSSiSn/c1-7-10-13-22(14-11-8-2,15-12-9-3)17-16-19-18(20-17)21(4,5)6/h16H,7-15H2,1-6H3
263868-71-9Relevant articles and documents
FUSED HETEROCYCLIC DERIVATIVES AND METHODS OF USE
-
Page/Page column 85, (2010/11/29)
Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
